Location History:
- Cincinnati, OH (US) (1993 - 1994)
- West Chester, OH (US) (1992 - 1996)
Company Filing History:
5 out of 455 
1 out of 832,812 Years Active: 1992-1996
Title: Marion W Wannamaker: Innovator in Cholesterol Biosynthesis Inhibition
Introduction
Marion W Wannamaker is a notable inventor based in West Chester, OH (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit cholesterol biosynthesis. With a total of 6 patents to her name, her work has had a meaningful impact on health and medicine.
Latest Patents
Among her latest patents are innovative compounds such as piperidyl amides, sulfonamides, and sulfoxamides. These compounds are recognized for their utility as inhibitors of cholesterol biosynthesis. Specifically, her invention of piperidyl amides is aimed at lowering total serum cholesterol in patients who require such treatment. Similarly, her piperidyl sulfonamides and sulfoxamides serve the same purpose, providing valuable options for managing cholesterol levels.
Career Highlights
Throughout her career, Marion has worked with reputable organizations, including Merrell Dow Pharmaceuticals. Her expertise in pharmaceutical innovation has positioned her as a key figure in the development of cholesterol-lowering agents.
Collaborations
Marion has collaborated with esteemed colleagues such as William R Moore and William A Van Sickle. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Marion W Wannamaker's contributions to the field of cholesterol biosynthesis inhibition exemplify her dedication to improving health outcomes. Her innovative patents and collaborations highlight her significant role in pharmaceutical advancements.